Endogenous IFNß expression predicts outcome in critical patients with COVID-19.

Menezes, Soraya Maria; Braz, Marcos; Llorens-Rico, Veronica; Wauters, Joost; Van Weyenbergh, Johan

Menezes, Soraya Maria; Braz, Marcos; Llorens-Rico, Veronica; Wauters, Joost; Van Weyenbergh, Johan.

Menezes SM; Laboratory of Clinical and Epidemiological Virology, KU Leuven, 3000 Leuven, Belgium.
Braz M; Laboratory of Clinical and Epidemiological Virology, KU Leuven, 3000 Leuven, Belgium.
Llorens-Rico V; Laboratory of Bacteriology, KU Leuven, 3000 Leuven, Belgium.
Wauters J; Department of Microbiology, Immunology and Transplantation, Rega Institute of Medical Research and Laboratory for Clinical Infectious and Inflammatory Disorders, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium.
Van Weyenbergh J; University Hospitals Leuven, Leuven, Belgium.

Lancet Microbe ; 2(6): e235-e236, 2021 06.

Article in English | MEDLINE | ID: covidwho-1169314

Subject(s)

COVID-19; Interferon-beta/metabolism; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Interferon-beta / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Lancet Microbe Year: 2021 Document Type: Article Affiliation country: S2666-5247(21)00063-X

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google